Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
AUTOR(ES)
Gulli, Salvatore
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=194711Documentos Relacionados
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
- Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody.
- Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
- Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.